HSBC Knock-Out ABBV/ DE000HS377E6 /
2024-07-26 4:35:19 PM | Chg.+0.310 | Bid4:48:35 PM | Ask4:48:35 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.890EUR | +8.66% | 3.870 Bid Size: 30,000 |
3.880 Ask Size: 30,000 |
AbbVie Inc | 144.0048 USD | 2078-12-31 | Call |
GlobeNewswire
07-01
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in A...
GlobeNewswire
06-28
NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
GlobeNewswire
06-28
Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Re...
GlobeNewswire
06-28
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
06-27
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Ach...
GlobeNewswire
06-25
CEREVEL (NASDAQ:CERE) STOCK ALERT: Cerevel’s $45 Per Share Deal is Being Investigated by BFA Law, Sh...
GlobeNewswire
06-24
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
06-22
CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law...
GlobeNewswire
06-21
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
06-20
CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law...
GlobeNewswire
06-20
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
06-19
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire
06-19
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire
06-18
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire
06-18
CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoi...
GlobeNewswire
06-17
Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, B...
GlobeNewswire
06-15
CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law abo...
GlobeNewswire
06-13
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...